	流动负债		日
Acadia Pharmaceuticals	USD 361.44M	55.91M	2026-06
Adma Biologics	USD 75.76M	2.22M	2026-06
ALKERMES	USD 662.09M	62.59M	2026-06
Alterity Therapeutics Limited	AUD 1.73M	2.77M	2025-12
AstraZeneca	USD 31.55B	1.02B	2026-06
BioCryst Pharmaceuticals	USD 208.85M	13.46M	2026-06
Bristol-Myers Squibb	USD 18.66B	499M	2026-06
Cipla	INR 70.14B	7.16B	2026-03
Clal Biotechnology	ILS 6.66M	3.75M	2023-12
Compugen	USD 22.04M	533K	2026-03
CSL	USD 4.61B	207M	2025-12
Eli Lilly	USD 47.74B	11.11B	2026-06
GlaxoSmithKline	GBP 21.53B	895M	2026-06
Grifols	EUR 2.37B	156.97M	2025-12
Halozyme Therapeutics	USD 344.44M	18.77M	2026-06
Ionis Pharmaceuticals	USD 315.64M	401.36M	2026-06
J&J	USD 54.9B	2.82B	2026-06
Merck	USD 27.73B	786M	2026-06
Minerva Neurosciences	USD 2.29M	381K	2025-12
Neurocrine Biosciences	USD 874.5M	42.8M	2026-06
Novartis	USD 31.75B	374M	2026-06
Novavax	USD 330.57M	11.89M	2026-06
Pfizer	USD 32.65B	1.7B	2026-06
Roche Holding	CHF 28.85B	846M	2026-06
Sanofi	EUR 31.93B	1.92B	2026-06
Takeda	JPY 2.76T	335.02B	2026-06
Vanda Pharmaceuticals	USD 145.16M	27.29M	2025-12